All Stories

  1. Reformatting palivizumab and motavizumab from IgG to human IgA impairs their efficacy against RSV infection in vitro and in vivo

    Article • mAbs, March 2018, Taylor & Francis

    Louis Bont

  2. Why is RSV different from other viruses?

    Article • Journal of Medical Virology, March 2013, Wiley

    Louis Bont